Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...
Rapamycin, a natural compound, has shown anti-aging and health benefits in various researches. Consequently, the popularity and demand for rapamycin supplements have surged significantly in the ...
Rapamycin shows promise in animal models, suggesting anti-aging potential Human trials are underway to explore its effects on aging-related diseases Side effects are manageable at lower doses, but ...